CA964581A - Combination of l-dopa,2-imino-5-phenyl-4-oxazolidi-none and an aluminum or alkaline earth metal salt or base used to treat parkinson's disease - Google Patents

Combination of l-dopa,2-imino-5-phenyl-4-oxazolidi-none and an aluminum or alkaline earth metal salt or base used to treat parkinson's disease

Info

Publication number
CA964581A
CA964581A CA126,240A CA126240A CA964581A CA 964581 A CA964581 A CA 964581A CA 126240 A CA126240 A CA 126240A CA 964581 A CA964581 A CA 964581A
Authority
CA
Canada
Prior art keywords
oxazolidi
dopa
imino
none
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA126,240A
Other languages
English (en)
Other versions
CA126240S (en
Inventor
Nicholas P. Plotnikoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of CA964581A publication Critical patent/CA964581A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA126,240A 1970-11-23 1971-10-27 Combination of l-dopa,2-imino-5-phenyl-4-oxazolidi-none and an aluminum or alkaline earth metal salt or base used to treat parkinson's disease Expired CA964581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9216670A 1970-11-23 1970-11-23
US11025671A 1971-01-27 1971-01-27

Publications (1)

Publication Number Publication Date
CA964581A true CA964581A (en) 1975-03-18

Family

ID=26785355

Family Applications (1)

Application Number Title Priority Date Filing Date
CA126,240A Expired CA964581A (en) 1970-11-23 1971-10-27 Combination of l-dopa,2-imino-5-phenyl-4-oxazolidi-none and an aluminum or alkaline earth metal salt or base used to treat parkinson's disease

Country Status (5)

Country Link
AU (1) AU3509971A (online.php)
CA (1) CA964581A (online.php)
DE (1) DE2157881A1 (online.php)
FR (1) FR2115239B1 (online.php)
GB (1) GB1322095A (online.php)

Also Published As

Publication number Publication date
FR2115239A1 (online.php) 1972-07-07
AU3509971A (en) 1973-05-03
DE2157881A1 (de) 1972-06-08
GB1322095A (en) 1973-07-04
FR2115239B1 (online.php) 1974-11-15

Similar Documents

Publication Publication Date Title
JPS56156265A (en) Manufacture of phenyl-imidazolyl-alkanyl derivative and its salt
CA959655A (en) Treatment of liquid metal
CA934270A (en) Vanne de detente d'un fluide sous pression
CA931789A (en) High strength titanium base alloy
IL36017A0 (en) New derivatives of 2,3-dihydro-5h-imidazoline and their preparation
CA964581A (en) Combination of l-dopa,2-imino-5-phenyl-4-oxazolidi-none and an aluminum or alkaline earth metal salt or base used to treat parkinson's disease
ZA717146B (en) Combination of l-dopa,2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinson's disease
BE765522A (fr) Preparation d'elements metalliques
ZA737695B (en) New derivatives of 2-amino-(1,2,3,4-tetrahydronaphthalene),the preparation and use thereof
AU452550B2 (en) The use of diphenylsulfones inthe treatment of mareks disease
ZA712390B (en) Noval additive alloy intended for the treatment of spheroidal graphite cast irons
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
CA939241A (en) Chemical treatment of metal
CA939353A (en) Manufacture of 1,1'-disubstituted-4,4'-bipyridylium salts and related compounds
ZA715494B (en) Treatment of parkinson's disease
CA954341A (en) Aluminum alloy and treatment therefor
ZA71461B (en) Method of treating parkinson's disease
GB1403674A (en) Metal salts of 1,4-dithiol-2,3-butanediol
AU455249B2 (en) Manufacature of 1,1'-disubstituted-4,4'-benpyridylium salts and related compounds
AU461236B2 (en) Combination of l-dops and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease
CA833502A (en) Magnesium-base alloy
CA843364A (en) Titanium steel alloy
AU2482771A (en) Manufacature of 1,1'-disubstituted-4,4'-benpyridylium salts and related compounds
CA850696A (en) Preparation of 3,4-dihaloanilines
CA835396A (en) Preparation of 3,4-dimethyl-8-nitroquinoline